Last reviewed · How we verify
Secondary glaucoma
Approved treatments
- Didroxan
- Keveyis
Keveyis works by inhibiting the enzyme carbonic anhydrase, which is involved in the production of aqueous humor in the eye. - Neptazane · Pfizer
- Diamox · Teva
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Secondary glaucoma patent landscape — cliff calendar, originator estates, attackable patents
- Secondary glaucoma treatment landscape brief
- Secondary glaucoma treatment updates RSS
Frequently asked questions about Secondary glaucoma
What drugs treat Secondary glaucoma?
Tracked treatments include Didroxan, Keveyis, Neptazane, Diamox.
What is the treatment for Secondary glaucoma?
Standard treatment for Secondary glaucoma includes Didroxan, Keveyis, Neptazane, Diamox. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Secondary glaucoma patent cliff · Secondary glaucoma CI report
- Treatment: Didroxan
- Treatment: Keveyis
- Treatment: Neptazane · Pfizer
- Treatment: Diamox · Teva
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing